小児虐待(Child Abuse)：世界の治験レビュー（2015年上半期版）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Child Abuse 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Child Abuse to Central Nervous System Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Subjects Recruited Over a Period of Time 20
Clinical Trials by Sponsor Type 21
Prominent Drugs 22
Clinical Trial Overview of Top Institutes / Government 23
Centers for Disease Control and Prevention 23
Clinical Trial Overview of Centers for Disease Control and Prevention 23
Duke University 24
Clinical Trial Overview of Duke University 24
National Institute of Mental Health 25
Clinical Trial Overview of National Institute of Mental Health 25
The Johns Hopkins University 26
Clinical Trial Overview of The Johns Hopkins University 26
Yale University 27
Clinical Trial Overview of Yale University 27
Allegheny-Singer Research Institute 28
Clinical Trial Overview of Allegheny-Singer Research Institute 28
Boston Medical Center 29
Clinical Trial Overview of Boston Medical Center 29
Georgia State University 30
Clinical Trial Overview of Georgia State University 30
Goethe-Universitat 31
Clinical Trial Overview of Goethe-Universitat 31
Harborview Injury Prevention & Research Center 32
Clinical Trial Overview of Harborview Injury Prevention & Research Center 32
Five Key Clinical Profiles 33
Appendix 48
Abbreviations 48
Definitions 48
Research Methodology 49
Secondary Research 49
About GlobalData 50
Contact Us 50
Disclaimer 50
Source 50